These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the concept of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant disorders. A research review posted https://jessicat692dbx3.wiki-cms.com/user